Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults

Clinical trial NCT03858075 · COMPLETED

Trial details

NCT number: NCT03858075
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2019-02-12
Primary completion: 2019-09-11
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.